<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>36(9)</volume><submitter>Tan RSJ</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>The clinical efficacy of corticosteroids remains unclear. The primary aim of this systematic review and meta-analysis was to evaluate the use of high-dose versus low- dose corticosteroids on the mortality rate of COVID-19 patients.&lt;h4>Design&lt;/h4>Systematic review and meta-analysis.&lt;h4>Setting&lt;/h4>Electronic search for randomized controlled trials and observational studies (MEDLINE, EMBASE, CENTRAL).&lt;h4>Participants&lt;/h4>Hospitalized adults ≥ 18 years old who were SARS-CoV-2 PCR positive.&lt;h4>Interventions&lt;/h4>High-dose and low-dose corticosteroids.&lt;h4>Measurements and main results&lt;/h4>A total of twelve studies (n=2759 patients) were included in this review. The pooled analysis demonstrated no significant difference in mortality rate between the high-dose and low-dose corti</pubmed_abstract><journal>Journal of cardiothoracic and vascular anesthesia</journal><pagination>3576-3586</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9101704</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis.</pubmed_title><pmcid>PMC9101704</pmcid><pubmed_authors>Xin CE</pubmed_authors><pubmed_authors>Tan RSJ</pubmed_authors><pubmed_authors>Hasan MS</pubmed_authors><pubmed_authors>Atan R</pubmed_authors><pubmed_authors>Ng KT</pubmed_authors><pubmed_authors>Yunos NM</pubmed_authors></additional><is_claimable>false</is_claimable><name>High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis.</name><description>&lt;h4>Objectives&lt;/h4>The clinical efficacy of corticosteroids remains unclear. The primary aim of this systematic review and meta-analysis was to evaluate the use of high-dose versus low- dose corticosteroids on the mortality rate of COVID-19 patients.&lt;h4>Design&lt;/h4>Systematic review and meta-analysis.&lt;h4>Setting&lt;/h4>Electronic search for randomized controlled trials and observational studies (MEDLINE, EMBASE, CENTRAL).&lt;h4>Participants&lt;/h4>Hospitalized adults ≥ 18 years old who were SARS-CoV-2 PCR positive.&lt;h4>Interventions&lt;/h4>High-dose and low-dose corticosteroids.&lt;h4>Measurements and main results&lt;/h4>A total of twelve studies (n=2759 patients) were included in this review. The pooled analysis demonstrated no significant difference in mortality rate between the high-dose and low-dose corti</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T19:52:11.302Z</modification><creation>2025-02-19T00:55:37.487Z</creation></dates><accession>S-EPMC9101704</accession><cross_references><pubmed>35715291</pubmed><doi>10.1053/j.jvca.2022.05.011</doi></cross_references></HashMap>